Dr. Brett Macaluso, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 550 Route 299, Suite 200, Highland, NY 12528 Phone: 845-231-5600 Fax: 845-231-5489 |
News Archive
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that Ruben Mesa, MD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 14, 2014 at the 19th Congress of European Hematology Association (EHA) which is being held in Milan, Italy, from June 12-15, 2014.
To sustain the efforts that have been made in the past three years to combat bullying, Highmark Healthy High 5, an initiative of the Highmark Foundation, is awarding an additional $3.3 million during the next two years to the Windber Research Institute (WRI) and the Center for Safe Schools (CSS).
The compulsory use of vaccines to prevent the effects of a bioterrorist attack seems to be based on an unproved threat, according to an editorial in this week's BMJ.
New York University College of Nursing received a two-year, $452,218.00 grant from the national Institutes of Health to research "Proinflammatory Biomarkers and Post-Breast Cancer Lymphedema."
The novel coronavirus has been compared to the flu almost from the moment it emerged in late 2019. They share a variety of symptoms, and in many cases, an influenza test is part of the process for diagnosing COVID-19.
› Verified 5 days ago